Rivaroxaban Viatris vascular 2
Rivaroxaban Viatris vascular 2 is a medicine authorised by Swissmedic under authorisation number 69320. The authorisation holder is Viatris Pharma GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 06 December 2023 and the authorisation is limited until 05 December 2028. ATC code B01AF01 places the medicine in the group Antithrombotic agents.
| Authorisation number | 69320 |
|---|---|
| Name | Rivaroxaban Viatris vascular 2 |
| Full name | Rivaroxaban Viatris vascular 2,5 mg, Filmtabletten |
| Authorisation holder | Viatris Pharma GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | B01AF01 |
| First authorisation | 06 December 2023 |
| Authorisation validity | 05 December 2028 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Rivaroxaban Viatris vascular 2,5 mg, Filmtabletten | B | 06 December 2023 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 56 | Tablette(n) | B01AF01 | 06.03.0. | B |
| 2 | 196 | Tablette(n) | B01AF01 | 06.03.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Rivaroxaban Viatris vascular 2 authorised in Switzerland?
Yes. Rivaroxaban Viatris vascular 2 is authorised by Swissmedic under authorisation number 69320, data as of 01 September 2026. The authorisation is limited until 05 December 2028.
Which dispensing category does Rivaroxaban Viatris vascular 2 have?
Rivaroxaban Viatris vascular 2 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Rivaroxaban Viatris vascular 2?
The authorisation holder is Viatris Pharma GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.